Korean Startup Apollon Wins CES 2025 Innovation Award for Non-Invasive Continuous Glucose Monitor
Korean startup Apollon has announced that it won the Digital Health Innovation Award at the world’s largest ICT exhibition, ‘2025 CES Innovation Awards.’
The award-winning device ‘MOGLU™’ is a wearable technology that detects glucose’s Raman signals within the body, enabling continuous blood glucose monitoring.
Apollon has gained attention through joint research with MIT, successfully miniaturizing the device by utilizing specific wavelength Raman signals. Currently, clinical trials are being conducted on the general population at the MIT Clinical Center, with Samsung Electronics and LG Electronics reportedly participating.
The CES Innovation Award, presented by the Consumer Technology Association (CTA), is given to products demonstrating innovation and technological prowess. In recent years, they have strengthened their assessment criteria, continuously reducing the number of awarded products. Specifically, in the Digital Health category, the number of awards dropped from 86 in 2023 to 56 in 2024, and further down to 47 in 2025 – almost halving in three years. Among the total 350 awarded products, Digital Health represents just 13%. In the Continuous Glucose Monitoring (CGM) field, despite global interest, only three companies worldwide have won innovation awards: Abbott (Lingo), Dexcom (Stelo), and Apollon (MOGLU).
Ah-ram Hong, Apollon’s CEO working at the US subsidiary in Cambridge, shared via email: “Winning the CES Innovation Award alongside Abbott and Dexcom on World Diabetes Day is deeply meaningful.” She added that based on general population clinical results, they’ve miniaturized the device to be smaller than a mobile phone, and plan to prepare patient clinical trials at the Harvard-affiliated Joslin Diabetes Center in the latter half of next year.
She also expressed the ambition to launch the first FDA-approved non-invasive continuous glucose monitor, reducing physical and economic burdens for diabetes patients.
Currently, Apollon’s US-based doctoral researchers are advancing optical systems, while the Korean team focuses on circuit design and software development to accelerate ultra-miniature device production.
MORE FROM THE POST
- MVITRO Named Featured Exhibitor at CES 2025 for Painless Laser Blood Sampling Device
- D&C biotechnology’s URINE CHECK-ER Wins Second Consecutive CES Innovation Award
- Team Elysium’s Bodydot Fitness Wins Innovation Award at CES 2025
- HAII Showcases AI-Based Digital Healthcare Services at CES 2025, Including World’s First Depression/Anxiety Diagnostic Tool
- Korean Sexual Wellness Brand ‘Barunsengkak’ Showcases Innovative Products at CES 2025
Share
Most Read
- 1
- 2
- 3
- 4
- 5
Leave a Reply